![]() Immuneering Immuneering is a biopharmaceutical company that develops medicines for the treatment of a spectrum of oncologic diseases. | |||
Founding Date | Founding Date N/A | Founding Date 2015 | Founding Date 2008 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Woburn, US HQ Milton, GB Woburn, US | Locations Cambridge, US HQ New York, US San Diego, US |
Employees | Employees 1 | Employees 10422% increase | Employees 5320% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 823.3 m | Valuation ($) 58.7 m |
Financial | |||
Net income | Net income N/A | Net income ($313.9m) (FY, 2026) | Net income ($56m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 12.1m | Total funding raised $ 30m | Total funding raised $ 57.2m |

Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View company
Immuneering is a biopharmaceutical company that develops medicines for the treatment of a spectrum of oncologic diseases.
View company